Search

everythinglearnresearchcommunity

for

Search:↓

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Anti-CD19 therapy may help treat SLE and NMOSD.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

The treatment with Shunyou and prednisone is effective and safe for lupus nephritis.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

The niosomes effectively target hair follicles for acne treatment.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Rats developed lung issues from the drugs, but these cleared quickly after stopping them.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Low-dose methotrexate, combined with surgical and local treatments, effectively treats severe vulvovaginal lichen planus.

Isotretinoin effectively treats severe acne and similar conditions, but has common, mostly reversible side effects, requiring careful patient monitoring.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Isotretinoin effectively treated severe acne in HIV-positive women, with improved skin and CD4 counts, but some experienced side effects like skin dryness and hair loss.

A woman recovered from hair loss and skin eruptions after stopping a tuberculosis drug and using steroids.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.